Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to refine ...

How to measure linearity of an ADC using sine-wave input. How do non-idealities of a sine wave affect ADC linearity while testing it. Testing an ADC’s linearity. To obtain the transfer function of an ...

An EDN Design Idea (DI) presented a discussion of how to increase the resolution of an ADC by adding a non-deterministic, zero-mean, Gaussian noise dither waveform to a signal to be converted; then, ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

ADC Therapeutics' primary focus is on the CD19-targeted antibody-drug conjugate Zynlonta, with key trials like LOTIS-5 and LOTIS-7 shaping its future prospects. Financially, ADCT holds $274.3 million ...

The ATMega168 is a great general purpose 8-bit AVR microcontroller from Atmel. It has 23 GPIO pins, but sometimes (as I have found) you can run out of I/O pins as your design grows. This happened to ...

looked at general static analog-to-digital converter (ADC) inaccuracy errors and ADC inaccuracy error that involves bandwidth. Hopefully, it also provided a greater ...

SDN and virtualization are driving a shift from hardware-based application delivery controllers toward a microservices model that enables more flexible ADC licensing options The application delivery ...